Pennington, NJ, United States of America

Nicole Cathleen Goodwin

USPTO Granted Patents = 13 (Patent Applications = 5)

CIPO Patents = 5

EPO Patents = 12 (Patent Applications = 13)

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 31(Granted Patents)

Location History:

Pennington, NJ (US) (2010 - 2018)
King of Prussia, PA (US) (2020 - 2021)

Company Filing History:

8 out of 86

Lexicon Pharmaceuticals, Inc.

patents

4 out of 230

Glaxosmithkline Intellectual Property Development Limited

patents

3 out of 123

Astex Therapeutics Limited

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12091409 - Ether linked triazoles as NRF2 activators (2024-09-17),

2. 11117905 - Bisaryl heterocycles as NRF2 activators (2021-09-14),

3. 11078216 - Bisaryl amides as NRF2 activators (2021-08-03),

4. 11059816 - Ether linked triazoles as NRF2 activators (2021-07-13),

5. 10604509 - Nrf2 regulators (2020-03-31),

6. 10106569 - Inhibitors of sodium glucose transporter 1 for constipation (2018-10-23),

7. 9688710 - Inhibitors of sodium glucose cotransporter 1 (2017-06-27),

8. 9200025 - Inhibitors of sodium glucose cotransporter 1 (2015-12-01),

9. 8450332 - LIMK2 inhibitors, compositions comprising them, and methods of their use (2013-05-28),

10. 8293878 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors (2012-10-23),

11. 8193202 - LIMK2 inhibitors, compositions comprising them, and methods of their use (2012-06-05),

12. 8026347 - Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors (2011-09-27),

13. 7781577 - Inhibitors of sodium glucose co-transporter 2 and methods of their use (2010-08-24),

Title: The Innovative Journey of Nicole Cathleen Goodwin

Introduction: Nicole Cathleen Goodwin, an accomplished inventor based in Pennington, NJ, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of eight patents, she has developed innovative solutions aimed at treating complex health issues.

Latest Patents: Among her notable patents are those focused on inhibitors of sodium glucose transporter 1 (SGLT1), specifically designed for the treatment of constipation and related diseases, including diabetes. These patents detail various compositions and methods utilizing specific compounds, underscoring Nicole's commitment to advancing medical science.

Career Highlights: Nicole has spent a significant part of her career at Lexicon Pharmaceuticals, Inc., where her work continues to push the boundaries of pharmaceutical innovation. Her extensive research and development efforts have been essential in creating treatments that improve patient outcomes.

Collaborations: Throughout her career, Nicole has collaborated with esteemed colleagues, including Bryce Alden Harrison and David Brent Rawlins. These collaborations have been instrumental in refining her inventions and expanding the impact of her work within the medical community.

Conclusion: Nicole Cathleen Goodwin stands out as a pioneering inventor in the pharmaceutical landscape. Her contributions have not only resulted in numerous patents but also in profound implications for the treatment of various health conditions. Her journey exemplifies the spirit of innovation that drives progress in science and medicine.

This text is generated by artificial intelligence and may not be accurate.